Workflow
OviTex
icon
Search documents
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
Globenewswire· 2025-06-03 20:05
Based on market research, inguinal hernia repair is the most common type of hernia repairMALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the European launch of OviTex Inguinal Reinforced Tissue Matrix, the only reinforced tissue matrix specifically engineered for laparoscopic and robotic-assisted inguinal hernia repair. This milestone follows the ...
TELA Bio(TELA) - 2025 Q1 - Earnings Call Transcript
2025-05-08 21:32
TELA Bio (TELA) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants Louisa Smith - PrincipalAntony Koblish - Co-Founder, CEO & PresidentRoberto Cuca - CFO & COOMichaela Smith - Equity Research Associate Conference Call Participants Frank Takkinen - Senior Research AnalystMichael Sarcone - AnalystDavid Turkaly - Research Analyst Operator Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter twenty twenty five Earnings Conference Call. At this time, all participants a ...
TELA Bio(TELA) - 2025 Q1 - Earnings Call Transcript
2025-05-08 21:30
TELA Bio (TELA) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Speaker0 Good afternoon, ladies and gentlemen, and welcome to the TELA Bio First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in listen only mode. Following the prepared remarks, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to turn the conference over to Louisa Smith from Gilmartin Group. Speaker1 Thank you, Gerald, and good a ...
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
Newsfilter· 2025-03-31 11:00
To learn more, visit ovitexprs.com. About TELA Bio, Inc. MALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ:TELA), a commercial- stage medical technology company focused on advancing soft-tissue reconstruction solutions, today announced the U.S. launch of larger sizes of OviTex PRS Reinforced Tissue Matrix, the only tissue-based device reinforced with polymer suture embroidery specifically engineered for plastic and reconstructive surgery. Designed for consistency in thickness, stretch, ...